Avenue Therapeutics, Inc.
ATXI
$0.80
$0.045.19%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 1.40M | 1.40M | -- | -- | -- |
| Total Revenue | 1.40M | 1.40M | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.40M | 1.40M | -- | -- | -- |
| SG&A Expenses | 3.99M | 4.27M | 4.82M | 4.64M | 4.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.33M | 7.76M | 9.48M | 11.28M | 11.81M |
| Operating Income | -3.93M | -6.36M | -9.48M | -11.28M | -11.81M |
| Income Before Tax | -3.78M | -6.18M | -9.21M | -11.70M | -9.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.78 | -6.18 | -9.21 | -11.70 | -9.52 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.00K | 38.00K | 41.00K | 44.00K | 52.00K |
| Net Income | -3.74M | -6.14M | -9.16M | -11.65M | -9.47M |
| EBIT | -3.93M | -6.36M | -9.48M | -11.28M | -11.81M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 3.10 | 1.39 | 2.74 | -12.04 | -13.58 |
| Normalized Basic EPS | -0.96 | -2.03 | -3.60 | -8.03 | -6.06 |
| EPS Diluted | 3.10 | 1.39 | 2.74 | -12.04 | -13.58 |
| Normalized Diluted EPS | -0.96 | -2.03 | -3.60 | -8.03 | -6.06 |
| Average Basic Shares Outstanding | 11.23M | 9.65M | 7.58M | 5.18M | 3.56M |
| Average Diluted Shares Outstanding | 11.23M | 9.65M | 7.58M | 5.18M | 3.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |